Expansion Momentum ChargePoint is expanding its manufacturing footprint in Europe, including a new single use facility in Speke, Liverpool, and broader EU capacity, signaling rising demand for contained and sterile transfer solutions and creating regional sales opportunities.

Single Use Leadership The new dedicated single use production facility underscores strong market demand for disposable containment and sterility transfer technologies, creating clear cross sell opportunities for single use transfer lines, valves, and related systems.

Automation Opportunity The launch of a robotic material handling solution demonstrates openness to automation in powder and solid dosage manufacturing, opening discussions for robotic integration, safety improvements, and efficiency upgrades with pharma manufacturers.

Global Footprint Strategic acquisitions and US expansion since 2021 and 2022, including Terracon, expand ChargePoint's regional reach and product portfolio, enabling coordinated selling strategies to global customers and new market segments.

Quality Edge ISO 13485 aligned and core focus on regulated pharmaceutical environments position ChargePoint as a trusted supplier for audits, validation runs, and compliant containment solutions for potent ingredients.